Follow
Pawel Buszman
Pawel Buszman
Medical University of Silesia
Verified email at ka.onet.pl
Title
Cited by
Cited by
Year
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute …
Authors/Task Force Members, CW Hamm, JP Bassand, S Agewall, J Bax, ...
European heart journal 32 (23), 2999-3054, 2011
49662011
Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology
Authors/Task Force Members, K Fox, MAA Garcia, D Ardissino, ...
European heart journal 27 (11), 1341-1381, 2006
21782006
Everolimus-eluting stents or bypass surgery for left main coronary artery disease
GW Stone, JF Sabik, PW Serruys, CA Simonton, P Généreux, J Puskas, ...
New England Journal of Medicine 375 (23), 2223-2235, 2016
11372016
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
S Windecker, PW Serruys, S Wandel, P Buszman, S Trznadel, A Linke, ...
The Lancet 372 (9644), 1163-1173, 2008
7782008
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents
PW Serruys, S Silber, S Garg, RJ van Geuns, G Richardt, PE Buszman, ...
New England journal of medicine 363 (2), 136-146, 2010
7592010
Five-year outcomes after PCI or CABG for left main coronary disease
GW Stone, AP Kappetein, JF Sabik, SJ Pocock, MC Morice, J Puskas, ...
New England Journal of Medicine 381 (19), 1820-1830, 2019
6832019
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy …
P Vranckx, M Valgimigli, P Jüni, C Hamm, PG Steg, D Heg, GA van Es, ...
The Lancet 392 (10151), 940-949, 2018
6752018
Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque
PW Serruys, HM García-García, P Buszman, P Erne, S Verheye, ...
Circulation 118 (11), 1172-1182, 2008
659*2008
Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left …
M Tendera, W Wojakowski, W Rużyłło, L Chojnowska, C Kępka, W Tracz, ...
European heart journal 30 (11), 1313-1321, 2009
5472009
Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization
PE Buszman, SR Kiesz, A Bochenek, E Peszek-Przybyla, I Szkrobka, ...
Journal of the American College of Cardiology 51 (5), 538-545, 2008
5022008
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS …
GG Stefanini, B Kalesan, PW Serruys, D Heg, P Buszman, A Linke, ...
The Lancet 378 (9807), 1940-1948, 2011
4072011
Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in …
PW Serruys, V Farooq, B Kalesan, T De Vries, P Buszman, A Linke, ...
JACC: Cardiovascular Interventions 6 (8), 777-789, 2013
3632013
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
J Escaned, C Collet, N Ryan, G Luigi De Maria, S Walsh, M Sabate, ...
European heart journal 38 (42), 3124-3134, 2017
3032017
Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial
JJ Wykrzykowska, S Garg, C Girasis, T De Vries, MA Morel, GA Van Es, ...
Journal of the American College of Cardiology 56 (4), 272-277, 2010
2832010
Mobilization of Bone Marrow-Derived Oct-4+ SSEA-4+ Very Small Embryonic-Like Stem Cells in Patients With Acute Myocardial Infarction
W Wojakowski, M Tendera, M Kucia, E Zuba-Surma, E Paczkowska, ...
Journal of the American College of Cardiology 53 (1), 1-9, 2009
2832009
Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the …
V Džavík, CE Buller, GA Lamas, JM Rankin, GBJ Mancini, WJ Cantor, ...
Circulation 114 (23), 2449-2457, 2006
2222006
4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A …
M Taniwaki, GG Stefanini, S Silber, G Richardt, P Vranckx, PW Serruys, ...
Journal of the American College of Cardiology 63 (16), 1617-1625, 2014
1932014
Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry
PE Buszman, PP Buszman, RS Kiesz, A Bochenek, B Trela, ...
Journal of the American College of Cardiology 54 (16), 1500-1511, 2009
1812009
Drug-eluting stent for left main coronary artery disease: the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass …
A Chieffo, E Meliga, A Latib, SJ Park, Y Onuma, P Capranzano, ...
JACC: Cardiovascular Interventions 5 (7), 718-727, 2012
1722012
Left main stenting in comparison with surgical revascularization: 10-year outcomes of the (left main coronary artery stenting) LE MANS trial
PE Buszman, PP Buszman, I Banasiewicz-Szkróbka, KP Milewski, ...
Cardiovascular Interventions 9 (4), 318-327, 2016
1652016
The system can't perform the operation now. Try again later.
Articles 1–20